Neurotrope BioScience's Reverse Merger Round

Neurotrope BioScience raised a round of funding on August 29, 2013. Investors include Neurotrope.

Neurotrope is a biopharmaceutical and diagnostics company principally focused on developing two product platforms, a diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for …

Articles about Neurotrope BioScience's Reverse Merger Round: